Yu Feifei, Huang Jingbin, Yu Yuan, Lu Ying, Chen Yan, Zhang He, Zhou Guichen, Sun Zhiguo, Liu Junjie, Sun Duxin, Zhang Guoqing, Zou Hao, Zhong Yanqiang
J Biomed Nanotechnol. 2016 Mar;12(3):503-15. doi: 10.1166/jbn.2016.2177.
Efficient gene release after intracellular uptake is very important for non-viral gene delivery systems. To construct a glutathione-responsive gene delivery system, we developed gold-cysteamine (AuCM)/plasmid DNA (pDNA)/poly TAT (pTAT)/hyaluronic acid (HA) nanocomplexes (AuCM/pDNA/pTAT/HA) in this study. The AuCM/pDNA/pTAT/HA nanocomplexes possessed a small size less than 200 nm and negative zeta potential of -17 ± 4 mV. The multilayer structure was verified by UV-Vis spectra, surface charges, dynamic light scattering. Morphology was observed by transmission electron microscope. The AuCM/pDNA/pTAT/HA nanocomplexes could completely protect pDNA against enzymatic degradation. These nanocomplexes showed effective cellular uptake in CD44 receptors over-expressed HepG 2 cells in a HA/CD44 interaction dependent manner. Moreover, transfection efficacy was significantly enhanced in AuCM/pDNA/pTAT/HA treated HepG 2 cells compared with AuCM/pDNA/pTAT, and was further enhanced in the presence of GSH, indicating that AuCM/pDNA/pTAT/HA was glutathione-responsive. Biodistribution revealed that AuCM/pDNA/pTAT/HA nanocomplexes mainly accumulated in liver. In conclusion, AuCM/pDNA/pTAT/HA nanocomplexes may serve as glutathione-responsive gene carriers for actively targeting gene delivery to CD44 receptors over-expressed liver cancers.
细胞内摄取后高效的基因释放对于非病毒基因递送系统非常重要。为构建一种谷胱甘肽响应性基因递送系统,我们在本研究中开发了金-半胱胺(AuCM)/质粒DNA(pDNA)/聚TAT(pTAT)/透明质酸(HA)纳米复合物(AuCM/pDNA/pTAT/HA)。AuCM/pDNA/pTAT/HA纳米复合物尺寸小于200 nm,zeta电位为-17±4 mV,呈阴性。通过紫外可见光谱、表面电荷、动态光散射对多层结构进行了验证,通过透射电子显微镜观察了形态。AuCM/pDNA/pTAT/HA纳米复合物能够完全保护pDNA不被酶降解。这些纳米复合物在HA/CD44相互作用依赖的方式下,在CD44受体过表达的HepG 2细胞中显示出有效的细胞摄取。此外,与AuCM/pDNA/pTAT相比,AuCM/pDNA/pTAT/HA处理的HepG 2细胞转染效率显著提高,并且在谷胱甘肽存在的情况下进一步提高,表明AuCM/pDNA/pTAT/HA具有谷胱甘肽响应性。生物分布显示AuCM/pDNA/pTAT/HA纳米复合物主要积聚在肝脏中。总之,AuCM/pDNA/pTAT/HA纳米复合物可作为谷胱甘肽响应性基因载体,用于将基因主动递送至CD44受体过表达的肝癌细胞。